Navigation Links
ExonHit Therapeutics - 2007 Financial Results
Date:3/5/2008

nt to EUR 5.4 million, a decrease of 5% compared to the EUR 5.6 million achieved in 2006. At constant exchange rate, total revenues would have increased 4% between 2006 and 2007. 89% of ExonHit's 2007 revenues come from the Allergan collaboration; this compares with 76% in 2006. While revenues generated by the Therapeutics and SpliceArray(TM) activities posted double-digit growth in 2007, revenues form the bioMerieux collaboration decreased due to, on the one hand, the delays experienced in the recruitment of samples in prostate cancer and, on the other hand, the milestone achieved in 2006 in this collaboration.

R&D revenues from grants increased from EUR 0.01 million in 2006 to EUR 0.05 million in 2007.

R&D expenses have increased by 27% to EUR 8.6 million in 2007 when compared to EUR 6.8 million in 2006, mainly as a result of increased expenses in clinical trials. In 2007, R&D revenues covered 62% of the company's R&D expenses, as opposed to 83% in 2006.

Marketing and selling expenses have increased by 31% to EUR 1.0 million in 2007, compared to EUR 0.8 million in 2006. This increase mainly comes from the recruitment of new employees in this department and the increase in the selling and marketing effort for SpliceArray(TM).

General and administrative costs increased by 16% to EUR 3.5 million in 2007, compared to EUR 3.0 million in 2006. This increase mainly comes from the substantial increase of study and consultancy fees between the two years as a result of increased expenses to value our IP.

Operating expenses have been increased by 24% to EUR 13.2 million in 2007 compared to EUR 10.6 million in 2006. In 2007, 65% of these expenses are allocated to R&D compared to 64% in 2006.

Consequently, the company posted an operating loss of EUR 7.8 million in 2007, compared to EUR 5.0 million in 2006.

The presence of convertible bonds throughout fiscal year 2007, as well as the leasing of some pieces of equipment, explains
'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
2. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
3. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
4. ExonHit and bioMerieux Amend Their Strategic Partnership
5. ExonHit Builds A New Organisation
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Washington, USA (PRWEB) September 30, 2014 ... yet efficient arrangements that have evolved in nature over ... biomimetic and bioinspired materials for applications in biophotonics ... Biomedical Optics . The journal is published by SPIE, ... SPIE Digital Library. Several of the peer-reviewed articles are ...
(Date:10/1/2014)... 2014 Slone Partners , a ... IT, and Laboratory Testing industries, reported a 120% increase ... director level and above from July 2013 to July ... top of rapid breakthroughs in diagnostics, reimbursement has failed ... have been forced to fold, consolidate, or carry on ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 The U.S. ... to Southern Illinois University Edwardsville as part of the ... initiative. The funding is co-administered by the Department of ... Biden, Secretary of Labor Thomas E. Perez and Secretary ... million in job-driven training grants to nearly 270 colleges ...
(Date:10/1/2014)... Industry leaders from retail ... around the theme, ,Commercial Opportunities in the Era of ... Elsevier , a world-leading provider of scientific, ... a gathering of some of the industry,s most prominent ... today and in the future. The Elsevier ...
Breaking Biology Technology:Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 2Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 3Slone Partners Meets Growing Demand as Industry Focuses on Reimbursement & Regulation 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 3U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 4Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3
... Protocol combines benefits of TRI Reagent , ... isolation , technology , ... flash-frozen, or RNAlater-treated tissues , ... throughput processing using multichannel pipettes or automated ...
... A variety of siRNA ... screening, require the efficient delivery of , ... studies describe performing transfections in 6 well and 24 , ... NeoFX Transfection Agent ...
... siRNA Electroporation Kit , , ... Deliver siRNA into primary cells, , ... cells , Maintain high cell viability under a wide , ... cells quickly with included positive and negative ...
Cached Biology Technology:High Throughput RNA Isolation for High Performance Microarray Analysis 2High Throughput RNA Isolation for High Performance Microarray Analysis 3High Throughput RNA Isolation for High Performance Microarray Analysis 4High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 2High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 3High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 4High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 5High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 6High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 7High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 8High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 9High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 10Deliver siRNAs Into Primary Cells 2Deliver siRNAs Into Primary Cells 3Deliver siRNAs Into Primary Cells 4Deliver siRNAs Into Primary Cells 5Deliver siRNAs Into Primary Cells 6
(Date:10/1/2014)... Soil microbes that thrive in the deserts, rainforests, prairies ... living beneath New York City,s Central Park, according to ... and the University of Colorado Boulder. , The ... Central Park,s 843 acres and discovered a stunning diversity ... documented before. , Only 8.5 percent to 16.2 ...
(Date:9/30/2014)... the University of California, San Diego, have completed the ... a method that uses the pixels in an image ... as mesh-free simulation. , The researchers, led by J.S. ... the Jacobs School of Engineering at UC San Diego, ... at the CompIMAGE,14 conference in Pittsburgh this month. Chen ...
(Date:9/30/2014)... watermelon, salmon, and strawberries all have in common? ... of chromosomes and are diploid, these organisms are all ... chromosomesseedless watermelon and salmon have 3 and 4 sets ... this might seem surprising, in fact most plant species ... over a century ago, but only recently, with the ...
Breaking Biology News(10 mins):Microbes in Central Park soil: If they can make it there, they can make it anywhere 2Microbes in Central Park soil: If they can make it there, they can make it anywhere 3First comprehensive meshfree numerical simulation of skeletal muscle tissue achieved 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 3Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 4
... the first time, scientists at Weill Cornell Medical College in ... mechanism that,s crucial to how brain cells communicate. In ... as to how key cellular processes -- called endocytosis and ... in this week,s online edition of Proceedings of the National ...
... appear to have been influenced by RNA polymerase II. ... DNA into messenger-RNA (mRNA), which in turn is the ... is highly conserved through evolution, with many of its ... Single-cell organisms were already in existence 500 million ...
... whose mothers, sisters or daughters test positive for a cancer-causing ... disease but are unaware of that risk. That is ... exploring how families communicate genetic test results. Like their female ... in the BRCA 1 or 2 genes. Male carriers ...
Cached Biology News:Breakthrough technology observes synapse in real time, supporting theory of vesicular recycling 2Breakthrough technology observes synapse in real time, supporting theory of vesicular recycling 3Evolution with a restricted number of genes 2Men unaware of their cancer risk when female relatives test positive for BRCA mutation 2
... Special optically clear polystyrene formulation , ... immunoassay applications , Plates are certified ... of variation , Eight-well strips fit ... loss while in use even if turned ...
...
... Pierce scientists developed the Easy-Titer Human IgM ... a simple, sensitive, and easy-to-perform assay for ... an ELISA. This kit incorporates a simple ... of IgM concentration from 15-500 ng/ml in ...
... Lipid adsorption and clarification reagent; Ideal ... purification of antibodies, proteins, nucleic acids, ... negligible cross-reactivity, and improves downstream processing; ... solid-phase, non-ionic adsorbent supplied as a ...
Biology Products: